NBTX Earnings & Financial Statements
Nanobiotix S.A.
$30.63
+$0.61(+2.03%)
43
Overall
40
Value
36
Tech
55
Quality
Market Cap
$1.56B
Volume
136.24K
52W Range
$19.14 - $57.14
Target Price
$64.00
NBTX earnings and financial statements: Nanobiotix S.A.'s income statement, balance sheet and cash flow statement, annual and quarterly.
NBTX Annual Financial Statements
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $4.42M | $6.15M | $4.78M | $2.65M | $2.51M |
| Cost of revenue | $11.61M | -$30.06M | - | - | - |
| Operating income | -$68.39M | -$26.78M | -$64.36M | -$49.80M | -$36.24M |
| EBITDA | - | - | -$49.93M | -$45.06M | -$31.83M |
| Net income | -$68.13M | -$39.70M | -$57.04M | -$47.00M | -$33.59M |
| EPS (diluted) | $-1.44 | $-1.08 | $-1.64 | $-1.35 | $-1.38 |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | $67.42M | $93.90M | $59.77M | $101.77M | $134.03M |
| Total liabilities | $133.13M | $95.74M | -$201.02M | -$115.64M | -$93.35M |
| Shareholders’ equity | -$65.70M | -$1.84M | $256.23M | $256.21M | $256.09M |
| Cash and equivalents | $49.74M | $75.28M | $41.40M | $83.92M | $119.15M |
| Long-term debt | $45.98M | $45.54M | - | - | - |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$19.55M | -$12.48M | -$37.10M | -$29.87M | -$27.54M |
| Capital expenditure | - | - | -$93.0K | -$242.0K | -$111.0K |
| Free cash flow | -$20.40M | -$12.81M | -$37.20M | -$30.11M | -$27.65M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBTX | $30.63 | +2.0% | 136.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |